Proven Connect

The translational research arm of Prostate Cancer Research (PCR). Born of 30 years experience in prostate cancer research, Proven Connect aims to support the commercialisation of prostate cancer innovations through investment, expertise in academic and translational research and a deep understanding of patient needs. Prostate cancer is the most common cancer in men and as populations around the world age, the incidence of cases will increase. Through increasing funding and support for cutting edge research Proven Connect aims to relieve the burden of the disease for men, their families and wider society. All profits raised through Proven Connect will be invested back into prostate cancer. If you would like to work with Proven Connect please contact us.